A continuation of research aimed at describing the catalytic mechanism
of the phosphoglucomutase reaction at the atomic level is posed. X-ray
diffraction studies of the crystalline enzyme and complexes thereof will
provide primary data. Supporting data will be obtained from solution
studies of the following: the interaction between the enzymic phosphate
group and the active site metal ion; bonding making/breaking in the
transition state; the importance of selected amino acid side chains that
line the catalytic cleft. One of the first goals will be to improve the
current molecular model of the enzyme by collecting and processing
higher-resolution diffraction data. A recently identified procedure that
produces an improved lattice during elimination of the salt used in
crystal growth will be developed further and employed. Use of this
procedure should allow formation of various complexes of the crystalline
enzyme that could not be obtained otherwise because of the salt present
in untreated crystals. (The physical basis for the apparent annealing
that accompanies this treatment will be probed, as a side issue -- and
possibly its generality, along with procedures for improving the crystal
growth process.) A variety of substrate, substrate analog, and
transition state-analog complexes, also involving alternative metal ions,
will be studied in the crystal phase by utilizing electron density-
difference maps. The objective will be to identify the basis of the
>1010-fold substrate binding-induced rate effect and the >1010-fold Mg2+-
induced activation previously observed. An evaluation of bonding within
the vanadate group of the transition-state analog complex via Raman
spectroscopy and the use of EPR spectroscopy to assess binding-induced
changes in interaction between bound Mn2+ and the phosphate group of the
enzyme, after labelling it with 17O, and NMR spectrometry with the 113Cd
enzyme will aid in interpreting X-ray diffraction results. An assessment
of the 18O-kinetic isotope effect in a reaction where transfer of the (-
PO32-) group of the enzyme to a suitable acceptor is rate-limiting also
will facilitate interpretation of models obtained from X-ray diffraction
studies, including that of a bound transition-state analog. The identity
of several surface residues within the unusually large active site cleft
of phosphoglucomutase will be altered by site-directed mutagenesis, with
initial emphasis on residues close to the catalytic site that seem too
far away to be involved directly in catalysis. Kinetically interesting
mutant proteins will be subjected to a thorough physical/chemical
evaluation.
No Sub Projects information available for 3R01GM008963-34S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01GM008963-34S1
Patents
No Patents information available for 3R01GM008963-34S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01GM008963-34S1
Clinical Studies
No Clinical Studies information available for 3R01GM008963-34S1
News and More
Related News Releases
No news release information available for 3R01GM008963-34S1
History
No Historical information available for 3R01GM008963-34S1
Similar Projects
No Similar Projects information available for 3R01GM008963-34S1